Real-Time and Label-Free Detection of the Prostate-Specific Antigen in Human Serum by a Polycrystalline Silicon Nanowire Field-Effect Transistor Biosensor
- 11 July 2013
- journal article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 85 (16), 7912-7918
- https://doi.org/10.1021/ac401610s
Abstract
In this research, we used a polycrystalline silicon nanowire field-effect transistor (poly-Si NWFET) as a biosensor that employs the sidewall spacer technique instead of an expensive electron beam lithography method. When compared with commercial semiconductor processes, the sidewall spacer technique has the advantages of simplicity and low cost. In this study, we employed a novel poly-Si NWFET device for real-time, label-free, and ultrahigh-sensitivity detection of prostate-specific antigen (PSA) in human serum. Since serum proteome is very complex containing high levels of salts and other interfering compounds, we hereby developed a standard operating procedure for real-sample pretreatment to keep a proper pH value and ionic strength of the desalted serum and also utilized Tween 20 to serve as the passivation agent by surface modification on the NWFET to reduce nonspecific binding for medical diagnostic applications. We first modified 3-aminopropyltriethoxysilane on the surface of a poly-Si nanowire device followed by glutaraldehyde functionalization, and the PSA antibodies were immobilized on the aldehyde terminal. While PSA was prepared in the buffers to maintain an appropriate pH value and ionic strength, the results indicated that the sensor could detect trace PSA at less than 5 fg/mL in a microfluidic channel. The novel poly-Si NWFET is developed as a diagnostic platform for monitoring prostate cancer and predicting the risk of early biochemical relapse.Keywords
This publication has 32 references indexed in Scilit:
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Label‐free detection techniques for protein microarrays: Prospects, merits and challengesProteomics, 2010
- Fabrication of silicon nanowire devices for ultrasensitive, label-free, real-time detection of biological and chemical speciesNature Protocols, 2006
- Application of DNA microarray technology in determining breast cancer prognosis and therapeutic responseExpert Opinion on Biological Therapy, 2005
- DNA microarray technology in nutraceutical and food safetyToxicology Letters, 2004
- Biosensors for detection of pathogenic bacteriaBiosensors and Bioelectronics, 1999
- The Use of Prostate Specific Antigen Density to Enhance the Predictive Value of Intermediate Levels of Serum Prostate Specific AntigenJournal of Urology, 1992
- Glossary for chemists of terms used in biotechnology (IUPAC Recommendations 1992)Pure and Applied Chemistry, 1992
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, 1991
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerThe New England Journal of Medicine, 1991